HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 19-SEP-12 4H6O TITLE STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX TITLE 2 WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-3,5-DIMETHYLPHENOXY) TITLE 3 BENZYL)-1H-IMIDAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROL 14-ALPHA DEMETHYLASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 28-481; COMPND 5 SYNONYM: TC14DM, CYP51; COMPND 6 EC: 1.14.13.70; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA CRUZI; SOURCE 3 ORGANISM_TAXID: 5693; SOURCE 4 STRAIN: TULAHUEN; SOURCE 5 GENE: CYP51; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HMS174; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCW KEYWDS STEROL 14-ALPHA DEMETHYLASE (CYP51), CYTOCHROME P450, HEME, KEYWDS 2 OXIDOREDUCTASE, MONOOXYGENASE, STEROL BIOSYNTHESIS, EUKARYOTIC KEYWDS 3 MEMBRANES, CYTOCHROME P450 FOLD, ENDOPLASMIC RETICULUM MEMBRANE, KEYWDS 4 OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.WAWRZAK,T.Y.HARGROVE,M.P.POLLASTRI,G.I.LEPESHEVA REVDAT 5 20-SEP-23 4H6O 1 REMARK SEQADV LINK REVDAT 4 15-NOV-17 4H6O 1 REMARK REVDAT 3 10-APR-13 4H6O 1 JRNL REVDAT 2 27-MAR-13 4H6O 1 JRNL REVDAT 1 20-MAR-13 4H6O 0 JRNL AUTH G.ANDRIANI,E.AMATA,J.BEATTY,Z.CLEMENTS,B.J.COFFEY, JRNL AUTH 2 G.COURTEMANCHE,W.DEVINE,J.ERATH,C.E.JUDA,Z.WAWRZAK,J.T.WOOD, JRNL AUTH 3 G.I.LEPESHEVA,A.RODRIGUEZ,M.P.POLLASTRI JRNL TITL ANTITRYPANOSOMAL LEAD DISCOVERY: IDENTIFICATION OF A JRNL TITL 2 LIGAND-EFFICIENT INHIBITOR OF TRYPANOSOMA CRUZI CYP51 AND JRNL TITL 3 PARASITE GROWTH. JRNL REF J.MED.CHEM. V. 56 2556 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23448316 JRNL DOI 10.1021/JM400012E REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 12800 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.264 REMARK 3 R VALUE (WORKING SET) : 0.263 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 681 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 814 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.3210 REMARK 3 BIN FREE R VALUE SET COUNT : 46 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3472 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 55 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : 0.18000 REMARK 3 B33 (A**2) : -0.27000 REMARK 3 B12 (A**2) : 0.09000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.416 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.429 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 53.001 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.864 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.836 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3625 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4909 ; 1.870 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 432 ; 5.361 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 162 ;34.028 ;23.395 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 640 ;18.353 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;17.398 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 525 ; 0.063 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2743 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3619 ; 8.070 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 37 ;19.068 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 3559 ; 6.333 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 28 A 477 REMARK 3 ORIGIN FOR THE GROUP (A): 9.5124 25.0177 18.8879 REMARK 3 T TENSOR REMARK 3 T11: 0.9181 T22: 0.1318 REMARK 3 T33: 0.2249 T12: 0.1240 REMARK 3 T13: -0.0865 T23: 0.0032 REMARK 3 L TENSOR REMARK 3 L11: 3.5559 L22: 5.7648 REMARK 3 L33: 4.4236 L12: -1.3543 REMARK 3 L13: 0.0156 L23: 0.9760 REMARK 3 S TENSOR REMARK 3 S11: -0.7476 S12: -0.3195 S13: 0.2856 REMARK 3 S21: 1.6365 S22: 0.4003 S23: -0.1059 REMARK 3 S31: 0.2585 S32: -0.4548 S33: 0.3473 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4H6O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1000075086. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-AUG-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : BE LENSES/DIAMOND LAUE MONO REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.640 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 8.800 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 39.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.64 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 0.39600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3K10 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MAGNESIUM CHLORIDE, POTASSIUM REMARK 280 PHOSPHATE, GLYCEROL, PEG 4000, CYMAL 4, PH 7.4, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.66500 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 149.33000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 149.33000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 74.66500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 612 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 27 REMARK 465 PRO A 216 REMARK 465 TRP A 217 REMARK 465 LEU A 218 REMARK 465 LEU A 219 REMARK 465 ARG A 220 REMARK 465 LEU A 221 REMARK 465 PRO A 222 REMARK 465 GLU A 251 REMARK 465 ALA A 252 REMARK 465 SER A 253 REMARK 465 LYS A 254 REMARK 465 ASP A 255 REMARK 465 ASN A 256 REMARK 465 ASN A 257 REMARK 465 THR A 258 REMARK 465 LYS A 478 REMARK 465 LEU A 479 REMARK 465 PRO A 480 REMARK 465 SER A 481 REMARK 465 HIS A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 HIS A 485 REMARK 465 HIS A 486 REMARK 465 HIS A 487 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 29 -1.01 69.06 REMARK 500 PHE A 41 -1.12 69.00 REMARK 500 ALA A 115 -131.45 57.68 REMARK 500 ASN A 157 -52.39 -133.42 REMARK 500 ALA A 212 -50.52 -134.53 REMARK 500 LYS A 321 -4.45 -54.17 REMARK 500 ASN A 467 2.47 -66.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 422 SG REMARK 620 2 HEM A 501 NA 88.8 REMARK 620 3 HEM A 501 NB 84.6 84.9 REMARK 620 4 HEM A 501 NC 85.2 168.1 84.2 REMARK 620 5 HEM A 501 ND 91.1 97.7 174.9 92.8 REMARK 620 6 NEE A 502 NAN 178.0 92.2 97.3 94.1 87.0 REMARK 620 N 1 2 3 4 5 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NEE A 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KSW RELATED DB: PDB REMARK 900 T.CRUZI CYP51 IN COMPLEX WITH VNF REMARK 900 RELATED ID: 3K1O RELATED DB: PDB REMARK 900 T.CRUZI CYP51 IN COMPLEX WITH ANTIFUNGAL DRUG POSACONAZOLE DBREF 4H6O A 29 481 UNP Q7Z1V1 CP51_TRYCC 28 481 SEQADV 4H6O MET A 27 UNP Q7Z1V1 INITIATING METHIONINE SEQADV 4H6O ALA A 28 UNP Q7Z1V1 ARG 28 ENGINEERED MUTATION SEQADV 4H6O LYS A 29 UNP Q7Z1V1 PRO 29 ENGINEERED MUTATION SEQADV 4H6O LYS A 30 UNP Q7Z1V1 THR 30 ENGINEERED MUTATION SEQADV 4H6O HIS A 482 UNP Q7Z1V1 EXPRESSION TAG SEQADV 4H6O HIS A 483 UNP Q7Z1V1 EXPRESSION TAG SEQADV 4H6O HIS A 484 UNP Q7Z1V1 EXPRESSION TAG SEQADV 4H6O HIS A 485 UNP Q7Z1V1 EXPRESSION TAG SEQADV 4H6O HIS A 486 UNP Q7Z1V1 EXPRESSION TAG SEQADV 4H6O HIS A 487 UNP Q7Z1V1 EXPRESSION TAG SEQRES 1 A 461 MET ALA LYS LYS THR PRO PRO VAL TYR PRO VAL THR VAL SEQRES 2 A 461 PRO PHE LEU GLY HIS ILE VAL GLN PHE GLY LYS ASN PRO SEQRES 3 A 461 LEU GLU PHE MET GLN ARG CYS LYS ARG ASP LEU LYS SER SEQRES 4 A 461 GLY VAL PHE THR ILE SER ILE GLY GLY GLN ARG VAL THR SEQRES 5 A 461 ILE VAL GLY ASP PRO HIS GLU HIS SER ARG PHE PHE SER SEQRES 6 A 461 PRO ARG ASN GLU ILE LEU SER PRO ARG GLU VAL TYR THR SEQRES 7 A 461 ILE MET THR PRO VAL PHE GLY GLU GLY VAL ALA TYR ALA SEQRES 8 A 461 ALA PRO TYR PRO ARG MET ARG GLU GLN LEU ASN PHE LEU SEQRES 9 A 461 ALA GLU GLU LEU THR ILE ALA LYS PHE GLN ASN PHE VAL SEQRES 10 A 461 PRO ALA ILE GLN HIS GLU VAL ARG LYS PHE MET ALA GLU SEQRES 11 A 461 ASN TRP LYS GLU ASP GLU GLY VAL ILE ASN LEU LEU GLU SEQRES 12 A 461 ASP CYS GLY ALA MET ILE ILE ASN THR ALA CYS GLN CYS SEQRES 13 A 461 LEU PHE GLY GLU ASP LEU ARG LYS ARG LEU ASN ALA ARG SEQRES 14 A 461 HIS PHE ALA GLN LEU LEU SER LYS MET GLU SER SER LEU SEQRES 15 A 461 ILE PRO ALA ALA VAL PHE MET PRO TRP LEU LEU ARG LEU SEQRES 16 A 461 PRO LEU PRO GLN SER ALA ARG CYS ARG GLU ALA ARG ALA SEQRES 17 A 461 GLU LEU GLN LYS ILE LEU GLY GLU ILE ILE VAL ALA ARG SEQRES 18 A 461 GLU LYS GLU GLU ALA SER LYS ASP ASN ASN THR SER ASP SEQRES 19 A 461 LEU LEU GLY GLY LEU LEU LYS ALA VAL TYR ARG ASP GLY SEQRES 20 A 461 THR ARG MET SER LEU HIS GLU VAL CYS GLY MET ILE VAL SEQRES 21 A 461 ALA ALA MET PHE ALA GLY GLN HIS THR SER THR ILE THR SEQRES 22 A 461 THR SER TRP SER MET LEU HIS LEU MET HIS PRO LYS ASN SEQRES 23 A 461 LYS LYS TRP LEU ASP LYS LEU HIS LYS GLU ILE ASP GLU SEQRES 24 A 461 PHE PRO ALA GLN LEU ASN TYR ASP ASN VAL MET ASP GLU SEQRES 25 A 461 MET PRO PHE ALA GLU ARG CYS VAL ARG GLU SER ILE ARG SEQRES 26 A 461 ARG ASP PRO PRO LEU LEU MET VAL MET ARG MET VAL LYS SEQRES 27 A 461 ALA GLU VAL LYS VAL GLY SER TYR VAL VAL PRO LYS GLY SEQRES 28 A 461 ASP ILE ILE ALA CYS SER PRO LEU LEU SER HIS HIS ASP SEQRES 29 A 461 GLU GLU ALA PHE PRO ASN PRO ARG LEU TRP ASP PRO GLU SEQRES 30 A 461 ARG ASP GLU LYS VAL ASP GLY ALA PHE ILE GLY PHE GLY SEQRES 31 A 461 ALA GLY VAL HIS LYS CYS ILE GLY GLN LYS PHE ALA LEU SEQRES 32 A 461 LEU GLN VAL LYS THR ILE LEU ALA THR ALA PHE ARG GLU SEQRES 33 A 461 TYR ASP PHE GLN LEU LEU ARG ASP GLU VAL PRO ASP PRO SEQRES 34 A 461 ASP TYR HIS THR MET VAL VAL GLY PRO THR LEU ASN GLN SEQRES 35 A 461 CYS LEU VAL LYS TYR THR ARG LYS LYS LYS LEU PRO SER SEQRES 36 A 461 HIS HIS HIS HIS HIS HIS HET HEM A 501 43 HET NEE A 502 22 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM NEE 1-[3-(4-CHLORO-3,5-DIMETHYLPHENOXY)BENZYL]-1H-IMIDAZOLE HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 NEE C18 H17 CL N2 O FORMUL 4 HOH *55(H2 O) HELIX 1 1 HIS A 44 ASN A 51 1 8 HELIX 2 2 ASN A 51 LEU A 63 1 13 HELIX 3 3 ASP A 82 HIS A 84 5 3 HELIX 4 4 GLU A 85 SER A 91 1 7 HELIX 5 5 GLU A 101 ILE A 105 5 5 HELIX 6 6 MET A 106 GLY A 111 1 6 HELIX 7 7 VAL A 114 ALA A 118 5 5 HELIX 8 8 PRO A 119 THR A 135 1 17 HELIX 9 9 ASN A 141 GLU A 156 1 16 HELIX 10 10 LEU A 167 PHE A 184 1 18 HELIX 11 11 ASP A 187 ARG A 191 5 5 HELIX 12 12 ASN A 193 SER A 206 1 14 HELIX 13 13 PRO A 224 LYS A 249 1 26 HELIX 14 14 ASP A 260 ALA A 268 1 9 HELIX 15 15 SER A 277 MET A 308 1 32 HELIX 16 16 HIS A 309 LYS A 311 5 3 HELIX 17 17 ASN A 312 LEU A 319 1 8 HELIX 18 18 LEU A 319 ASP A 324 1 6 HELIX 19 19 ASN A 331 MET A 339 1 9 HELIX 20 20 MET A 339 ASP A 353 1 15 HELIX 21 21 SER A 383 HIS A 388 1 6 HELIX 22 22 GLY A 424 GLU A 442 1 19 HELIX 23 23 THR A 465 GLN A 468 5 4 SHEET 1 A 5 VAL A 67 ILE A 72 0 SHEET 2 A 5 GLN A 75 VAL A 80 -1 O VAL A 77 N ILE A 70 SHEET 3 A 5 ILE A 379 CYS A 382 1 O ALA A 381 N VAL A 80 SHEET 4 A 5 VAL A 359 VAL A 363 -1 N ARG A 361 O ILE A 380 SHEET 5 A 5 LEU A 97 SER A 98 -1 N SER A 98 O MET A 362 SHEET 1 B 3 GLY A 163 ASN A 166 0 SHEET 2 B 3 LEU A 470 ARG A 475 -1 O VAL A 471 N ILE A 165 SHEET 3 B 3 TYR A 443 LEU A 447 -1 N GLN A 446 O LYS A 472 LINK SG CYS A 422 FE HEM A 501 1555 1555 2.22 LINK FE HEM A 501 NAN NEE A 502 1555 1555 2.04 SITE 1 AC1 18 TYR A 103 TYR A 116 LEU A 134 ALA A 291 SITE 2 AC1 18 GLY A 292 THR A 295 PRO A 355 VAL A 359 SITE 3 AC1 18 ARG A 361 GLY A 414 PHE A 415 GLY A 416 SITE 4 AC1 18 HIS A 420 CYS A 422 ILE A 423 GLY A 424 SITE 5 AC1 18 ALA A 428 NEE A 502 SITE 1 AC2 6 TYR A 116 LEU A 130 ALA A 287 ALA A 291 SITE 2 AC2 6 THR A 295 HEM A 501 CRYST1 63.290 63.290 223.995 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015800 0.009122 0.000000 0.00000 SCALE2 0.000000 0.018245 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004464 0.00000